Patent Grant
RE49884
The present invention relates generally to the field of imaging and evaluating analytical samples. More particularly, the invention relates to a technique for imaging and evaluating analytical samples on multiple surfaces of a support structure using a compensator.
There are an increasing number of applications for imaging of analytical samples on a support structure. These support structures may include plates upon which biological samples are present. For instance, these plates may include deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) probes that are specific for nucleotide sequences present in genes in humans and other organisms. Individual DNA or RNA probes can be attached at specific locations in a small geometric grid or array on the support structure. Depending upon the technology employed, the samples may attach at random, semi-random or predetermined locations on the support structure. A test sample, such as from a known person or organism, can be exposed to the array or grid, such that complementary genes or fragments hybridize to probes at the individual sites on a surface of a plate. In certain applications, such as sequencing, templates or fragments of genetic material may be located at the sites, and nucleotides or other molecules may be caused to hybridize to the templates to determine the nature or sequence of the templates. The sites can then be examined by scanning specific frequencies of light over the sites to identify which genes or fragments in the sample were present, by fluorescence of the sites at which genes or fragments hybridized.
These plates are sometimes referred to as microarrays, gene or genome chips, DNA chips, gene arrays, and so forth, and may be used for expression profiling, monitoring expression levels, genotyping, sequencing, and so forth. For example, diagnostic uses may include evaluation of a particular patient's genetic makeup to determine whether a disease state is present or whether pre-disposition for a particular condition exists. The reading and evaluation of such plates are an important aspect of their utility. Although microarrays allow separate biological components to be presented for bulk processing and individual detection, the number of components that can be detected in a single experiment is limited by the resolution of the system. Furthermore, the bulk reagents used in some methods can be expensive such that reduced volumes are desired. The present invention provides methods and compositions that increase the efficiency of array based detection to counteract these limitations. Other advantages are provided as well and will be apparent from the description below.
The present invention provides a novel approach to analytical sample imaging and evaluation that expands the use of imaging and evaluation subsystems to multiple surfaces that support samples. The support structure may, for instance, be a flow cell through which a reagent fluid is allowed to flow and interact with biological samples. Excitation radiation from at least one radiation source may be used to excite the biological samples on multiple surfaces. In this manner, fluorescent radiation may be emitted from the biological samples and subsequently captured and detected by detection optics and at least one detector. The returned radiation may then be used to generate image data. This imaging of multiple surfaces may be accomplished either sequentially or simultaneously. In addition, the techniques of the present invention may be used with any of a variety of types of imaging systems. For instance, both epifluorescent and total internal reflection (TIR) methods may benefit from the techniques of the present invention. In addition, the biological samples imaged may be present on the surfaces of the support structure in random locations or in patterns.
Accordingly, the invention provides a method for imaging a biological sample. The method includes detecting radiation emitted from a first emissive component of a biological sample disposed on a first surface of a flow cell using a detector. The flow cell is mounted on an imaging station. The method also includes inserting corrective optics between the detector and the flow cell. The method further includes detecting radiation emitted from a second emissive component of a biological sample disposed on a second surface of the flow cell using the detector and the corrective optics. The first and second surfaces are in an arrangement whereby one of the surfaces is disposed between the detector and the other surface. In addition, the corrective optics reduce aberration of detection at one of the surfaces due to the arrangement. The steps of the method are repeated while maintaining the flow cell on the imaging station.
The invention further provides an imaging system for detecting radiation on a multi-surface flow cell. The imaging system includes a multi-surface flow cell having first and second emissive components of a biological sample disposed on respective first and second surfaces of the flow cell. The imaging system also includes an optical train including an objective, imaging optics configured to focus the optical train on the first emissive component via the objective, and corrective optics configured to focus the optical train on the second emissive component and configured to reduce aberration of detection at the first or second emissive component. The imaging system further includes a radiation source configured to direct excitation radiation towards the first and second emissive components. In addition, the imaging system includes detection optics configured to capture emitted radiation returned from the first and second emissive components via the optical train. Further, the imaging system includes a detector for detecting the captured radiation.
Turning now to the drawings, and referring first to
Those skilled in the art will recognize that a flow cell or other support structure may be used with any of a variety of arrays known in the art to achieve similar results. Furthermore, known methods for making arrays can be used, and if appropriate, modified in accordance with the teaching set forth herein in order to create a flow cell or other support structure having multiple surfaces useful in the detection methods set forth herein. Such arrays may be formed by disposing the biological components of samples randomly or in predefined patterns on the surfaces of the support by any known technique. In a particular embodiment, clustered arrays of nucleic acid colonies can be prepared as described in U.S. Pat. No. 7,115,400; U.S. Patent Application Publication No. 2005/0100900; PCT Publication No. WO 00/18957; or PCT Publication No. WO 98/44151, each of which is hereby incorporated by reference. Such methods are known as bridge amplification or solid-phase amplification and are particularly useful for sequencing applications.
Other exemplary random arrays, and methods for their construction, that can be used in the invention include, without limitation, those in which beads are associated with a solid support, examples of which are described in U.S. Pat. Nos. 6,355,431; 6,327,410; and U.S. Pat. No. 6,770,441; U.S. Patent Application Publication Nos. 2004/0185483 and US 2002/0102578; and PCT Publication No. WO 00/63437, each of which is hereby incorporated by reference. Beads can be located at discrete locations, such as wells, on a solid-phase support, whereby each location accommodates a single bead.
Any of a variety of other arrays known in the art or methods for fabricating such arrays can be used in the present invention. Commercially available microarrays that can be used include, for example, an Affymetrix® GeneChip® microarray or other microarray synthesized in accordance with techniques sometimes referred to as VLSIPS™ (Very Large Scale Immobilized Polymer Synthesis) technologies as described, for example, in U.S. Pat. Nos. 5,324,633; 5,744,305; 5,451,683; 5,482,867; 5,491,074; 5,624,711; 5,795,716; 5,831,070; 5,856,101; 5,858,659; 5,874,219; 5,968,740; 5,974,164; 5,981,185; 5,981,956; 6,025,601; 6,033,860; 6,090,555; 6,136,269; 6,022,963; 6,083,697; 6,291,183; 6,309,831; 6,416,949; 6,428,752; and 6,482,591, each of which is hereby incorporated by reference. A spotted microarray can also be used in a method of the invention. An exemplary spotted microarray is a CodeLink™ Array available from Amersham Biosciences. Another microarray that is useful in the invention is one that is manufactured using inkjet printing methods such as SurePrint™ Technology available from Agilent Technologies.
Sites or features of an array are typically discrete, being separated with spaces between each other. The size of the sites and/or spacing between the sites can vary such that arrays can be high density, medium density, or lower density. High density arrays are characterized as having sites separated by less than about 15 μm. Medium density arrays have sites separated by about 15 to 30 μm, while low density arrays have sites separated by greater than 30 μm. An array useful in the invention can have sites that are separated by less than 100 μm, 50 μm, 10 μm, 5 μm, 1 μm or 0.5 μm. An apparatus or method of the invention can be used to image an array at a resolution sufficient to distinguish sites at the above densities or density ranges.
As exemplified herein, a surface used in an apparatus or method of the invention is typically a manufactured surface. It is also possible to use a natural surface or a surface of a natural support structure; however the invention can be carried out in embodiments where the surface is not a natural material or a surface of a natural support structure. Accordingly, components of biological samples can be removed from their native environment and attached to a manufactured surface.
Any of a variety of biological components can be present on a surface for use in the invention. Exemplary components include, without limitation, nucleic acids such as DNA or RNA, proteins such as enzymes or receptors, polypeptides, nucleotides, amino acids, saccharides, cofactors, metabolites or derivatives of these natural components. Although the apparatus and methods of the invention are exemplified herein with respect to components of biological samples, it will be understood that other samples or components can be used as well. For example, synthetic samples can be used such as combinatorial libraries, or libraries of compounds having species known or suspected of having a desired structure or function. Thus, the apparatus or methods can be used to synthesize a collection of compounds and/or screen a collection of compounds for a desired structure or function.
Returning to the exemplary system of
For ease of description, embodiments utilizing fluorescence-based detection are used as examples. However, it will be understood that other detection methods can be used in connection with the apparatus and methods set forth herein. For example, a variety of different emission types can be detected such as fluorescence, luminescence, or chemiluminescence. Accordingly, components to be detected can be labeled with compounds or moieties that are fluorescent, luminescent, or chemiluminescent. Signals other than optical signals can also be detected from multiple surfaces using apparatus and methods that are analogous to those exemplified herein with the exception of being modified to accommodate the particular physical properties of the signal to be detected.
Output from the radiation sources 22, 24 may be directed through conditioning optics 26, 28 for filtering and shaping of the beams. For example, in a presently contemplated embodiment, the conditioning optics 26, 28 may generate a generally linear beam of radiation, and combine beams from multiple lasers, for example, as described in U.S. Pat. No. 7,329,860. The laser modules can additionally include a measuring component that records the power of each laser. The measurement of power may be used as a feedback mechanism to control the length of time an image is recorded in order to obtain uniform exposure, and therefore more readily comparable signals.
After passing through the conditioning optics 26, 28, the beams may be directed toward directing optics 30 which redirect the beams from the radiation sources 22, 24 toward focusing optics 32. The directing optics 30 may include a dichroic mirror configured to redirect the beams toward the focusing optics 32 while also allowing certain wavelengths of a retrobeam to pass therethrough. The focusing optics 32 may confocally direct radiation to one or more surfaces 18, 20 of the support structure 16 upon which individual biological components 12, 14 are located. For instance, the focusing optics 32 may include a microscope objective that confocally directs and concentrates the radiation sources 22, 24 along a line to a surface 18, 20 of the support structure 16.
Biological component sites on the support structure 16 may fluoresce at particular wavelengths in response to an excitation beam and thereby return radiation for imaging. For instance, the fluorescent components may be generated by fluorescently tagged nucleic acids that hybridize to complementary molecules of the components or to fluorescently tagged nucleotides that are incorporated into an oligonucleotide using a polymerase. As noted above, the fluorescent properties of these components may be changed through the introduction of reagents into the support structure 16 (e.g., by cleaving the dye from the molecule, blocking attachment of additional molecules, adding a quenching reagent, adding an acceptor of energy transfer, and so forth). As will be appreciated by those skilled in the art, the wavelength at which the dyes of the sample are excited and the wavelength at which they fluoresce will depend upon the absorption and emission spectra of the specific dyes. Such returned radiation may propagate back through the directing optics 30. This retrobeam may generally be directed toward detection optics 34 which may filter the beam such as to separate different wavelengths within the retrobeam, and direct the retrobeam toward at least one detector 36.
The detector 36 may be based upon any suitable technology, and may be, for example, a charged coupled device (CCD) sensor that generates pixilated image data based upon photons impacting locations in the device. However, it will be understood that any of a variety of other detectors may also be used including, but not limited to, a detector array configured for time delay integration (TDI) operation, a complementary metal oxide semiconductor (CMOS) detector, an avalanche photodiode (APD) detector, a Geiger-mode photon counter, or any other suitable detector. TDI mode detection can be coupled with line scanning as described in U.S. Pat. No. 7,329,860.
The detector 36 may generate image data, for example, at a resolution between 0.1 and 50 microns, which is then forwarded to a control/processing system 38. In general, the control/processing system 38 may perform various operations, such as analog-to-digital conversion, scaling, filtering, and association of the data in multiple frames to appropriately and accurately image multiple sites at specific locations on a sample. The control/processing system 38 may store the image data and may ultimately forward the image data to a post-processing system (not shown) where the data are analyzed. Depending upon the types of sample, the reagents used, and the processing performed, a number of different uses may be made of the image data. For example, nucleotide sequence data can be derived from the image data, or the data may be employed to determine the presence of a particular gene, characterize one or more molecules at the component sites, and so forth. The operation of the various components illustrated in
The support structure 16 may be supported on a translation system 40 which allows for focusing and movement of the support structure 16 before and during imaging. The stage may be configured to move the support structure 16, thereby changing the relative positions of the radiation sources 22, 24 and detector 36 with respect to the surface bound biological components for progressive scanning Movement of the translation system 40 can be in one or more dimensions including, for example, one or both of the dimensions that are orthogonal to the direction of propagation for the excitation radiation line, typically denoted as the X and Y dimensions. In particular embodiments, the translation system 40 may be configured to move in a direction perpendicular to the scan axis for a detector array. A translation system 40 useful in the present invention may be further configured for movement in the dimension along which the excitation radiation line propagates, typically denoted as the Z dimension. Movement in the Z dimension can also be useful for focusing.
The support structure 16 may be irradiated by excitation radiation 48 along a radiation line 50. The radiation line 50 may be formed by the excitation radiation 48 from the radiation sources 22, 24, directed by the directing optics 30 through the focusing optics 32. The radiation sources 22, 24 may generate beams that are processed and shaped to provide a linear cross section or radiation line including a plurality of wavelengths of radiation used to cause fluorescence at correspondingly different wavelengths from the biological components 12, 14, depending upon the particular dyes used. The focusing optics 32 may then semi-confocally direct the excitation radiation 48 toward the first surface 18 of the support structure 16 to irradiate sites of biological component 12 along the radiation line 50. In addition, the support structure 16, the directing optics 30, the focusing optics 32, or some combination thereof, may be slowly translated such that the resulting radiation line 50 progressively irradiates the component as indicated by the arrow 52. This translation results in successive scanning of regions 54 which allow for the gradual irradiation of the entire first surface 18 of the support structure 16. As will be discussed in more detail below, the same process may also be used to gradually irradiate the second surface 20 of the support structure 16. Indeed, the process may be used for multiple surfaces within the support structure 16.
Exemplary methods and apparatus for line scanning are described in U.S. Pat. No. 7,329,860, which is incorporated herein by reference, and which describes a line scanning apparatus having a detector array configured to achieve confocality in the scanning axis by restricting the scan-axis dimension of the detector array. More specifically, the scanning device can be configured such that the detector array has rectangular dimensions such that the shorter dimension of the detector is in the scan-axis dimension and imaging optics are placed to direct a rectangular image of a sample region to the detector array such that the shorter dimension of the image is also in the scan-axis dimension. In this way, semi-confocality can be achieved since confocality occurs in a single axis (i.e. the scan axis). Thus, detection is specific for features on the surface of a substrate, thereby rejecting signals that may arise from the solution around the feature. The apparatus and methods described in U.S. Pat. No. 7,329,860 can be modified such that two or more surfaces of a support are scanned in accordance with the description herein.
Detection apparatus and methods other than line scanning can also be used. For example, point scanning can be used as described below or in U.S. Pat. No. 5,646,411, which is incorporated herein by reference. Wide angle area detection can be used with or without scanning motion. As set forth in further detail elsewhere herein, TIR methods can also be used.
As illustrated generally in
It should be noted that the system will typically form and direct excitation and returned radiation simultaneously for imaging. In some embodiments, confocal point scanning may be used such that the optical system directs an excitation point or spot across a biological component by scanning the excitation beam through an objective lens. The detection system images the emission from the excited point on the detector without “descanning” the retrobeam. This occurs since the retrobeam is collected by the objective lens and is split off the excitation beam optical path before returning back through the scan means. Therefore, the retrobeam will appear on the detector 36 at different points depending on the field angle of the original excitation spot in the objective lens. The image of the excitation point, at the detector 36, will appear in the shape of a line as the excitation point is scanned across the sample. This architecture is useful, for example, if the scan means cannot for some reason accept the retrobeam from the sample. Examples are holographic and acoustic optic scan means that are able to scan a beam at very high speeds but utilize diffraction to create the scan. Therefore, the scan properties are a function of wavelength. The retrobeam of emitted radiation is at a different wavelength from the excitation beam. Alternatively or additionally, emission signals may be collected sequentially following sequential excitation at different wavelengths.
In particular embodiments, an apparatus or method of the invention can detect features on a surface at a rate of at least about 0.01 mm2/sec. Depending upon the particular application of the invention, faster rates can also be used including, for example, in terms of the area scanned or otherwise detected, a rate of at least about 0.02 mm2/sec, 0.05 mm2/sec, 0.1 mm2/sec, 1 mm2/sec, 1.5 mm2/sec, 5 mm2/sec, 10 mm2/sec, 50 mm2/sec, 100 mm2/sec, or faster. If desired, for so example, to reduce noise, the detection rate can have an upper limit of about 0.05 mm2/sec, 0.1 mm2/sec, 1 mm2/sec, 1.5 mm2/sec, 5 mm2/sec, 10 mm2/sec, 50 mm2/sec, or 100 mm2/sec.
In some instances, the support structure 16 may be used in such a way that biological components are expected to be present on only one surface. However, in many instances, biological material is present on multiple surfaces within the support structure 16. For instance,
Although the embodiment exemplified in
The distribution of biological components 12, 14 may follow many different patterns. For instance,
For instance,
The present techniques accommodate such varied physical arrangements of the multiple surfaces within the support structure 16, as well as the varied disposition of the sites within components on the surfaces. As discussed above with reference to
In more complex configurations, it may be useful to irradiate more than two surfaces. For instance,
In certain embodiments, the objective 92 may be designed for diffraction-limited focusing and imaging on only one of the first or second surfaces 18, 20 of the support structure 16. For example throughout the present description of
It should be noted that the need for a compensator may be more pronounced when using objectives 92 with high numerical aperture (NA) values. Exemplary high NA ranges for which the invention is particularly useful include NA values of at least about 0.6. For example, the NA may be at least about 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, or higher. Those skilled in the art will appreciate that NA, being dependent upon the index of refraction of the medium in which the lens is working, may be higher including, for example, up to 1.0 for air, 1.33 for pure water, or higher for other media such as oils. The compensator may also find use in objectives having lower NA values than the examples listed above. In general, the NA value of an objective 92 is a measure of the breadth of angles for which the objective 92 may receive light. The higher the NA value, the more light that may be collected by the objective 92 for a given fixed magnification. This is because the collection efficiency and the resolution increase. As a result, multiple objects may be distinguished more readily when using objectives 92 with higher NA values because a higher feature density may be possible. Therefore, in general, a higher NA value for the objective 92 may be beneficial for imaging. However, as the NA value increases, its sensitivity to focusing and imaging-through media thickness variation also increases. In other words, lower NA objectives 92 have longer depth of field and are generally not as sensitive to changes in imaging-through media thickness.
To balance out the spherical aberration, it is beneficial to introduce an additional thickness (e.g., by introducing an additional coverslip) between the objective 92 and the support structure 16. For instance, returning now to
However, merely introducing an additional thickness between the objective 92 and the support structure 16 may not be desired for all uses of the imaging system set forth herein. For instance, as illustrated in
For example,
The chromatic shift curve may be limited to wavelength ranges of between 530 nm to 780 nm. Chromatic shifts of different color wavelength bands may be compensated for by focusing the focusing optics 32 in each band. The compensator 110 should preferably be “invisible” to the focusing optics 32. In other words, the compensator 110 should correct the spherical aberration difference of the read buffer but should maintain the chromatic shift curve in the wavelength range of 530-780 nm. More specifically, the chromatic shift relationships among the peak wavelengths of 560 nm, 610 nm, 687 nm, and 720 nm should be maintained. In addition, other specifications, including NA, field curvature, field distortion, detection magnification, and so forth, should also be maintained. Furthermore, the compensator 110 package should be relatively small (e.g., no more than 10 mm of total thickness). Moreover, insensitivity to positioning error of the compensator 110 may be preferred.
Several various designs may be implemented to introduce the corrective optics of the compensator 110 into the optical train of the imaging optics of the biological sample imaging system 10. For example,
In addition to the embodiments presented in
Regardless of the particular embodiment selected, all of the embodiments disclosed herein are characterized by repeatability and the ability to automate the use of the embodiments. These are important considerations in that the embodiments allow for the detection of images from biological components 12, 14 on multiple surfaces 18, 20 of the support structure 16 in an automated fashion. This may allow not only for increased imaging production but may also allow for greater flexibility in switching between the multiple surfaces, depending on the particular imaging needs.
As described in greater detail above, a support structure 16 useful in the apparatus or methods set forth herein can have two or more surfaces upon which a biological component is attached. In particular embodiments, the surface is a fabricated surface. Any of a variety of surfaces known in the art can be used including, but not limited to, those used for making arrays as set forth above. Examples include, glass, silicon, polymeric structures, plastics, and the like. Surfaces and flow cells that are particularly useful are described in PCT Publication No. WO 2007/123744, which is incorporated herein by reference. The surfaces of a support structure can have the same or different properties. For example, in the embodiment shown in
A support structure having two or more surfaces can be formed by adhering the surfaces to each other or to other supports. For example, an adhesive material, such as epoxy resin, can be dispensed in the form of a paste onto a planar substrate in a pattern forming one or more channel characteristics of a flow cell. An exemplary flow cell 124 is shown in
An exemplary method 140 for fabricating such a flow cell is shown in
Another exemplary method for fabricating a flow cell is to use an intermediate layer that is cut to a desired pattern in place of an adhesive layer. A particularly useful material for the intermediate layer is silicone. The silicone layer can be heat bonded to the lower substrate 128 and upper substrate 132. Exemplary methods utilizing Bisco Silicone HT 6135 as an intermediate layer are described, for example, in Grover et al., Sensors and Actuators B 89:315-323 (2003).
Still further,
Alternatively,
In the embodiments described above where scanning of the first and second surfaces 18, 20 of the support structure 16 may be performed sequentially, the individual steps of scanning the first and second surfaces 18, 20 of the support structure 16 may be performed in a number of ways. For instance, it may be possible to scan a single line of the first surface 18, then scan a single line of the second surface 20, then gradually move the first and second surfaces 18, 20 relative to the excitation radiation 58, 62 by translating the support structure 16, the directing optics 30, the focusing optics 32, or some combination thereof, in order to repeat these steps of scanning individual lines. Alternatively, entire regions of the first surface 18 may be scanned before regions of the second surface 20 are scanned. The individual processing steps taken may depend upon several variables including the particular configuration of the biological component sites 12, 14 on the surfaces 18, 20 as well as other variables, including environmental and operating conditions.
Particular embodiments may allow for simultaneous excitation of multiple surfaces of the support structure 16. For instance,
For instance,
In the embodiments described above where scanning of the first and second surfaces 18, 20 of the support structure 16 may be performed simultaneously, focusing of the excitation radiation 58 source may be accomplished in several various ways. For instance, it may be possible to focus the excitation radiation 58 on one of the surfaces preferentially over the other surface. In fact, due to the nature of the configuration of the first surface 18 with respect to the second surface 20, it may be necessary to do so. However, alternate focusing techniques may be employed depending on the specific configuration of the support structure 16. Moreover, it may be advantageous in these various configurations to first image the upper surface (i.e., the surface closer to the radiation source) in order to reduce photobleaching of the components on that surface that could result from first imaging the lower surface (i.e., the surface farther from the radiation source). Such selection of which surface to image may apply both when the surfaces are imaged sequentially as well as when they are imaged simultaneously.
In addition, the embodiments disclosed above have illustrated an epifluorescent imaging scheme wherein the excitation radiation is directed toward the surfaces of the support structure 16 from a top side, and returned fluorescent radiation is received from the same side. However, the techniques of the present invention may also be extended to alternate arrangements. For instance, these techniques may also be employed in conjunction with TIR imaging whereby the surfaces of the support structure are irradiated from a lateral side with radiation directed at an incident angle within a range of critical angles so as to convey the excitation radiation within the support or into the support from a prism positioned adjacent to it. TIR techniques can be carried out as described, for example, in U.S. Patent Application Publication No. 2005/0057798, which is hereby incorporated by reference. Such techniques cause fluorescent emissions from the components that are conveyed outwardly for imaging, while the reflected excitation radiation exits via a side opposite from that through which it entered. Here again, biological components on the multiple surfaces may be imaged sequentially or simultaneously.
For example, in
As discussed in further detail below, as long as the incident angle of the radiation beam 196 is within the range of critical angles (as described, for example, in US 2005/0057798), a portion of the radiation beam 196 will be reflected off the bottom surface whereas a separate fluorescent emission beam from surface-bound emissive components will be directed toward focusing optics 198. Typically, a well collimated radiation beam is used to prevent spread of angles within the beam, thereby preventing unwanted hindrance of total internal reflectance. The fluorescent emission beam may propagate back through the focusing optics 198, directing optics 200, and detection optics 202 which may direct the beam toward a detector 204. The focusing optics 198, directing optics 200, detection optics 202, and detector 204 may operate in much the same manner as with the epifluorescent techniques discussed above. In the TIR biological sample imaging system 186, the focusing light source 206 may be used as a separate light source from the radiation source 194 to focus the optics on a particular surface to be imaged. For instance, the focusing light source 206 may be directed to the directing optics 200 where it is redirected toward the focusing optics 198 which are used to focus the system on a particular surface of the support structure 188.
The TIR biological sample imaging system 186 may also include a translation system 208 for moving the support structure 188 and prism 192 in one or more dimensions. The translation system 208 may be used with focusing, redirecting the radiation source 194 to different areas of the support structure 188, as well as for moving the support structure 188 and prism 192 to a heating/cooling station 210. The heating/cooling station 210 may be used to heat and cool the support structure 188 before and after imaging. In addition, a control/processing system 212 may be used to control operation of the radiation source 194, the focusing light source 206, and the heating/cooling station 210, movement and focusing of the focusing optics 198, the translation system 208, and the detection optics 202, and acquisition and processing of signals from the detector 204.
As discussed above, the TIR method of imaging may be used to direct the radiation beam 196 from a lateral side of the support structure 188, as illustrated in
Therefore, the orientation of the radiation source 194 and/or the support structure 188 and prism 192 may be adjusted in order to allow the radiation beam 196 to not be directed at a bottom surface 214 of a flow lane 190 of the support structure 188, as illustrated in
In order to accomplish this TIR imaging of top surfaces 216 of the flow lanes 190 of the support structure 188, the radiation beam 196 reaches the air/glass interface 224 of the support structure 188 unperturbed. To do so, the radiation beam 196 does not first come into contact with emissive components in adjacent flow lanes 190. To do so, either the radiation beam 196 may be directed around the adjacent flow lanes 190 or the adjacent flow lanes 190 may be index matched with the support structure 188 material. In some embodiments, the flow lanes 190 may be spaced within the support structure 188, leaving sufficient room between the flow lanes 190 for the radiation beam 196 to pass. However, spacing the flow lanes 190 in this manner may ultimately reduce the amount of emissive components which may be imaged. Therefore, in other embodiments, it may be possible to accomplish the same effect by temporarily filling alternate flow lanes 190 with index matching fluid. Doing so may allow for easier direction of the radiation beam 196 toward a top surface 216 of a flow lane 190 of the support structure 188.
It may also be possible to direct the radiation beam 196 in such a way that it bounces off multiple top surfaces 216 of flow lanes 190 of the support structure 188, as illustrated in
In some embodiments, mirrors 226 or other suitable reflective material may be used within certain flow lanes 190, facilitating this multi-bounce technique. In any event, assuming N number of flow lanes 190, it may only be possible to image N-2 number of top surfaces 216 of the flow lanes 190 in this manner due to the fact that the outer flow lanes 190 on either side of the support structure 188 may not be accessible using these techniques. However, modification of the prism 192 and/or support structure 188 may allow for imaging of the top surfaces 216 of these outermost flow lanes 190. For instance, the support structure 188 may be designed to fit within the prism 192, allowing the radiation beam 196 to propagate into a lateral side of the support structure 188.
In some embodiments, as discussed above briefly with respect to
In particular embodiments, the current invention utilizes sequencing-by-synthesis (SBS). In SBS, four fluorescently labeled modified nucleotides are used to determine the sequence of nucleotides for nucleic acids present on the surface of a support structure such as a flow cell. Exemplary SBS systems and methods which can be utilized with the apparatus and methods set forth herein are described in U.S. Pat. No. 7,057,026; U.S. Patent Application Publication Nos. 2005/0100900, 2006/0188901, 2006/0240439, 2006/0281109, and 2007/0166705; and PCT Publication Nos. WO 05/065814, WO 06/064199, and WO 07/010251; each of which is incorporated herein by reference.
In particular uses of the apparatus and methods herein, flow cells containing arrayed nucleic acids are treated by several repeated cycles of an overall sequencing process. The nucleic acids are prepared such that they include an oligonucleotide primer adjacent to an unknown target sequence. To initiate the first SBS sequencing cycle, one or more differently labeled nucleotides and a DNA polymerase are flowed into the flow cell. Either a single nucleotide can be added at a time, or the nucleotides used in the sequencing procedure can be specially designed to possess a reversible termination property, thus allowing each cycle of the sequencing reaction to occur simultaneously in the presence of all four labeled nucleotides (A, C, T, G). Following nucleotide addition, the features on the surface can be imaged to determine the identity of the incorporated nucleotide (based on the labels on the nucleotides). Then, reagents can be added to the flow cell to remove the blocked 3′ terminus (if appropriate) and to remove labels from each incorporated base. Such cycles are then repeated and the sequence of each cluster is read over the multiple chemistry cycles.
Other sequencing methods that use cyclic reactions wherein each cycle includes steps of delivering one or more reagents to nucleic acids on a surface and imaging the surface bound nucleic acids can also be used such as pyrosequencing and sequencing by ligation. Useful pyrosequencing reactions are described, for example, in U.S. Pat. No. 7,244,559 and U.S. Patent Application Publication No. 2005/0191698, each of which is incorporated herein by reference. Sequencing by ligation reactions are described, for example, in Shendure et al. Science 309:1728-1732 (2005); and U.S. Pat. Nos. 5,599,675 and 5,750,341, each of which is incorporated herein by reference.
The methods and apparatus described herein are also useful for detection of features occurring on surfaces used in genotyping assays, expression analyses and other assays known in the art such as those described in U.S. Patent Application Publication Nos. 2003/0108900, 2003/0215821, and US 2005/0181394, each of which is incorporated herein by reference.
While only certain features of the invention have been illustrated and described herein, many modifications and changes will occur to those skilled in the art. It is, therefore, to be understood that the appended claims are intended to cover all such modifications and changes as fall within the true spirit of the invention.
More than one reissue application of U.S. Pat. No. 9,365,898 has been filed. This application is a continuation reissue of U.S. patent application Ser. No. 16/000,720, filed Jun. 5, 2018, which issued as U.S. Pat. No. RE48,561 on May 18, 2021, which is herein incorporated in its entirety by reference, which is a continuation reissue of U.S. patent application Ser. No. 15/926,322, filed Mar. 20, 2018, which issued as U.S. Pat. No. RE48,219 on Sep. 22, 2020, which is herein incorporated in its entirety by reference, which is an application for reissue of U.S. Pat. No. 9,365,898, which issued on June 14, 2016 from U.S. patent application Ser. No. 14/721,870, which is herein incorporated in its entirety by reference, which is a continuation of U.S. patent application Ser. No. 14/229,455, entitled “Compensator for Multiple Surface Imaging,” filed Mar. 28, 2014, and issued as U.S. Pat. No. 9,068,220 on Jun. 30, 2015, which is herein incorporated in its entirety by reference, and which is a continuation of U.S. patent application Ser. No. 14/056,590, entitled “Compensator for Multiple Surface Imaging,” filed Oct. 17, 2013, and issued as U.S. Pat. No. 8,698,102 on Apr. 15, 2014, which is herein incorporated in its entirety by reference, and which is a continuation of U.S. patent application Ser. No. 13/974,976, entitled “Compensator for Multiple Surface Imaging,” filed Aug. 23, 2013, and issued as U.S. Pat. No. 8,586,947 on Nov. 19, 2013, which is herein incorporated in its entirety by reference, and which is a continuation of U.S. patent application Ser. No. 13/629,949, entitled “Compensator for Multiple Surface Imaging,” filed Sep. 28, 2012, and issued as U.S. Pat. No. 8,546,772 on Oct. 1, 2013, which is herein incorporated in its entirety by reference, and which is a continuation of U.S. patent application Ser. No. 13/544,716, entitled “Compensator for Multiple Surface Imaging,” filed Jul. 9, 2012, and issued as U.S. Pat. No. 8,278,630 on Oct. 2, 2012, which is herein incorporated in its entirety by reference, and which is a continuation of U.S. patent application Ser. No. 13/399,820, entitled “Compensator for Multiple Surface Imaging,” filed Feb. 17, 2012, and issued as U.S. Pat. No. 8,242,463 on Aug. 14, 2012, which is herein incorporated in its entirety by reference, and which is a continuation of U.S. patent application Ser. No. 13/281,237, entitled “Compensator for Multiple Surface Imaging,” filed Oct. 25, 2011, and issued as U.S. Pat. No. 8,143,599 on Mar. 27, 2012, which is herein incorporated in its entirety by reference, and which is a continuation of U.S. patent application Ser. No. 13/209,306, entitled “Compensator for Multiple Surface Imaging,” filed Aug. 12, 2011, and issued as U.S. Pat. No. 8,071,962 on Dec. 6, 2011, which is herein incorporated in its entirety by reference, and which is a continuation of U.S. patent application Ser. No. 12/434,495, entitled “Compensator for Multiple Surface Imaging,” filed May 1, 2009, and issued as U.S. Pat. No. 8,039,817 on Oct. 18, 2011, which is herein incorporated in its entirety by reference, and which claims priority of U.S. Provisional patent application Ser. No. 61/050,522, entitled “Multi-Surface Biological Sample Imaging System and Method,” filed May 5, 2008, which is herein incorporated in its entirety by reference, and of U.S. Provisional patent application Ser. No. 61/138,444, entitled “Compensator for Multiple Surface Imaging,” filed Dec. 17, 2008, which is herein incorporated in its entirety by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3950649 | Yonekubo | Apr 1976 | A |
| 4222743 | Wang | Sep 1980 | A |
| 4563062 | Kanatani | Jan 1986 | A |
| 5184021 | Smith | Feb 1993 | A |
| 5324633 | Fodor et al. | Jun 1994 | A |
| 5422712 | Ogino | Jun 1995 | A |
| 5451683 | Barrett et al. | Sep 1995 | A |
| 5482867 | Barrett et al. | Jan 1996 | A |
| 5491074 | Aldwin et al. | Feb 1996 | A |
| 5599675 | Brenner | Feb 1997 | A |
| 5624711 | Sundberg et al. | Apr 1997 | A |
| 5646411 | Kain et al. | Jul 1997 | A |
| 5744305 | Fodor et al. | Apr 1998 | A |
| 5750341 | Macevicz | May 1998 | A |
| 5795716 | Chee | Aug 1998 | A |
| 5831070 | Pease et al. | Nov 1998 | A |
| 5856101 | Hubbell et al. | Jan 1999 | A |
| 5858659 | Sapolsky et al. | Jan 1999 | A |
| 5874219 | Rava et al. | Feb 1999 | A |
| 5945334 | Besemer et al. | Aug 1999 | A |
| 5968740 | Fodor | Oct 1999 | A |
| 5974164 | Chee | Oct 1999 | A |
| 5981185 | Matson et al. | Nov 1999 | A |
| 5981956 | Stern | Nov 1999 | A |
| 6022963 | McGall et al. | Feb 2000 | A |
| 6025601 | Trulson et al. | Feb 2000 | A |
| 6033860 | Lockhart et al. | Mar 2000 | A |
| 6083697 | Beecher et al. | Jul 2000 | A |
| 6090555 | Fiekowsky et al. | Jul 2000 | A |
| 6136269 | Winkler et al. | Oct 2000 | A |
| 6291183 | Pirrung et al. | Sep 2001 | B1 |
| 6309831 | Goldberg | Oct 2001 | B1 |
| 6321791 | Chow | Nov 2001 | B1 |
| 6327410 | Walt et al. | Dec 2001 | B1 |
| 6355431 | Chee et al. | Mar 2002 | B1 |
| 6416949 | Dower et al. | Jul 2002 | B1 |
| 6428752 | Montagu | Aug 2002 | B1 |
| 6440748 | Katerkamp et al. | Aug 2002 | B1 |
| 6482591 | Lockhart et al. | Nov 2002 | B2 |
| 6509085 | Kennedy | Jan 2003 | B1 |
| 6569382 | Edman et al. | May 2003 | B1 |
| 6582660 | Heller et al. | Jun 2003 | B1 |
| 6644944 | Karp | Nov 2003 | B2 |
| 6652808 | Heller et al. | Nov 2003 | B1 |
| 6770441 | Dickinson et al. | Aug 2004 | B2 |
| 6776094 | Whitesides et al. | Aug 2004 | B1 |
| 6844184 | Kim et al. | Jan 2005 | B2 |
| 6919211 | Fodor et al. | Jul 2005 | B1 |
| 6967074 | Duffy et al. | Nov 2005 | B2 |
| 7030383 | Babayoff et al. | Apr 2006 | B2 |
| 7033819 | Kim et al. | Apr 2006 | B2 |
| 7057026 | Barnes et al. | Jun 2006 | B2 |
| 7067306 | Singhvi et al. | Jun 2006 | B2 |
| 7109458 | Fairyley et al. | Sep 2006 | B2 |
| 7115400 | Adessi et al. | Oct 2006 | B1 |
| 7244559 | Rothberg et al. | Jul 2007 | B2 |
| 7329860 | Feng et al. | Feb 2008 | B2 |
| 7344627 | Broadley et al. | Mar 2008 | B2 |
| 7351376 | Quake et al. | Apr 2008 | B1 |
| 7445027 | Flachsbart et al. | Nov 2008 | B2 |
| 7473453 | Fisher | Jan 2009 | B2 |
| 8039817 | Feng et al. | Oct 2011 | B2 |
| 8071962 | Feng et al. | Dec 2011 | B1 |
| 8143599 | Feng et al. | Mar 2012 | B2 |
| 8242463 | Feng et al. | Aug 2012 | B2 |
| 8278630 | Feng et al. | Oct 2012 | B1 |
| 8313906 | Cao et al. | Nov 2012 | B2 |
| 8323900 | Handique et al. | Dec 2012 | B2 |
| 8357530 | Matsunaga et al. | Jan 2013 | B2 |
| 8372577 | Tanaka et al. | Feb 2013 | B2 |
| 8398936 | Horiuchi et al. | Mar 2013 | B2 |
| 8445194 | Drmanac et al. | May 2013 | B2 |
| 8507180 | Washio et al. | Aug 2013 | B2 |
| 8546772 | Feng et al. | Oct 2013 | B2 |
| 8586947 | Feng et al. | Nov 2013 | B1 |
| 8637242 | Washio et al. | Jan 2014 | B2 |
| 8698102 | Feng et al. | Apr 2014 | B2 |
| 8702948 | Ronaghi et al. | Apr 2014 | B2 |
| 8778849 | Bowen et al. | Jul 2014 | B2 |
| 8820883 | Wang et al. | Sep 2014 | B2 |
| 8900529 | Shaikh et al. | Dec 2014 | B2 |
| 8951716 | Liu et al. | Feb 2015 | B2 |
| 8951781 | Reed et al. | Feb 2015 | B2 |
| 9039997 | Cohen et al. | May 2015 | B2 |
| 9068220 | Feng et al. | Jun 2015 | B2 |
| 9073962 | Fracchia et al. | Jul 2015 | B2 |
| 9114396 | Tsai et al. | Aug 2015 | B2 |
| 9352315 | Tsai et al. | May 2016 | B2 |
| 9365898 | Feng et al. | Jun 2016 | B2 |
| 9458485 | Schultz et al. | Oct 2016 | B2 |
| 9512422 | Barnard et al. | Dec 2016 | B2 |
| 9515159 | Bischopink et al. | Dec 2016 | B2 |
| 9656260 | Tsai et al. | May 2017 | B2 |
| 9764505 | Guenther et al. | Sep 2017 | B2 |
| 9809852 | Esfandyarpour et al. | Nov 2017 | B2 |
| 9958465 | Ang et al. | May 2018 | B2 |
| 10486153 | Tsai et al. | Nov 2019 | B2 |
| RE48219 | Feng et al. | Sep 2020 | E |
| RE48561 | Feng et al. | May 2021 | E |
| 11298697 | Tsai et al. | Apr 2022 | B2 |
| 20020030811 | Schindler | Mar 2002 | A1 |
| 20020094572 | Singhvi et al. | Jul 2002 | A1 |
| 20020102578 | Dickinson | Aug 2002 | A1 |
| 20020139936 | Dumas | Oct 2002 | A1 |
| 20020143111 | Halverson et al. | Oct 2002 | A1 |
| 20030008310 | Williams et al. | Jan 2003 | A1 |
| 20030011772 | Abe et al. | Jan 2003 | A1 |
| 20030032048 | Kim et al. | Feb 2003 | A1 |
| 20030108900 | Oliphant | Jun 2003 | A1 |
| 20030112432 | Yguerabide | Jun 2003 | A1 |
| 20030152490 | Trulson et al. | Aug 2003 | A1 |
| 20030156992 | Anderson et al. | Aug 2003 | A1 |
| 20030215821 | Gunderson et al. | Nov 2003 | A1 |
| 20040096831 | Hughes | May 2004 | A1 |
| 20040121066 | Anderson et al. | Jun 2004 | A1 |
| 20040175710 | Haushalter | Sep 2004 | A1 |
| 20040185483 | Stuelpnagel et al. | Sep 2004 | A1 |
| 20040248287 | Hu et al. | Dec 2004 | A1 |
| 20050057798 | Osborne et al. | Mar 2005 | A1 |
| 20050064432 | Huang et al. | Mar 2005 | A1 |
| 20050100900 | Kawashima et al. | May 2005 | A1 |
| 20050181394 | Steemers et al. | Aug 2005 | A1 |
| 20050191698 | Chee et al. | Sep 2005 | A1 |
| 20050205422 | Moser et al. | Sep 2005 | A1 |
| 20050221271 | Murphy et al. | Oct 2005 | A1 |
| 20050236361 | Ufer et al. | Oct 2005 | A1 |
| 20050272142 | Horita | Dec 2005 | A1 |
| 20060065528 | Lopez et al. | Mar 2006 | A1 |
| 20060188901 | Barnes et al. | Aug 2006 | A1 |
| 20060240439 | Smith et al. | Oct 2006 | A1 |
| 20060253035 | Stern | Nov 2006 | A1 |
| 20060281109 | Ost et al. | Dec 2006 | A1 |
| 20060292611 | Berka et al. | Dec 2006 | A1 |
| 20070000866 | Ryan et al. | Jan 2007 | A1 |
| 20070085334 | Watanabe et al. | Apr 2007 | A1 |
| 20070114362 | Feng et al. | May 2007 | A1 |
| 20070166705 | Milton et al. | Jul 2007 | A1 |
| 20080202694 | Serbicki et al. | Aug 2008 | A1 |
| 20080261288 | Gonda et al. | Oct 2008 | A1 |
| 20080262747 | Kain et al. | Oct 2008 | A1 |
| 20080274905 | Green | Nov 2008 | A1 |
| 20080297911 | Christenson et al. | Dec 2008 | A1 |
| 20090068759 | Arenas et al. | Dec 2009 | A1 |
| 20090298191 | Whitesides et al. | Dec 2009 | A1 |
| 20090309049 | Van Dijk et al. | Dec 2009 | A1 |
| 20100111768 | Bnerjee et al. | May 2010 | A1 |
| 20100193704 | Pratt | Aug 2010 | A1 |
| 20100210008 | Strand et al. | Aug 2010 | A1 |
| 20100233696 | Joseph et al. | Sep 2010 | A1 |
| 20100327184 | Hayashi | Dec 2010 | A1 |
| 20110091864 | Karlsson et al. | Apr 2011 | A1 |
| 20110195260 | Lee et al. | Aug 2011 | A1 |
| 20120004140 | Staker | Jan 2012 | A1 |
| 20120182609 | Borenstein et al. | Jul 2012 | A1 |
| 20120184046 | Atkin | Jul 2012 | A1 |
| 20120319180 | Chuang et al. | Dec 2012 | A1 |
| 20130186575 | Fujita et al. | Jul 2013 | A1 |
| 20130199732 | Niwa et al. | Aug 2013 | A1 |
| 20130344290 | Yu et al. | Dec 2013 | A1 |
| 20140155297 | Heinz | Jun 2014 | A1 |
| 20140243224 | Barnard et al. | Aug 2014 | A1 |
| 20140256030 | Shen et al. | Sep 2014 | A1 |
| 20140272719 | Liu et al. | Sep 2014 | A1 |
| 20140349870 | Aizenberg et al. | Nov 2014 | A1 |
| 20140371091 | Wiktor et al. | Dec 2014 | A1 |
| 20150045234 | Stone et al. | Feb 2015 | A1 |
| 20150087007 | Meldrum et al. | Mar 2015 | A1 |
| 20150375226 | Yoo | Dec 2015 | A1 |
| 20160023208 | Fisher et al. | Jan 2016 | A1 |
| 20160318016 | Hou et al. | Nov 2016 | A1 |
| 20170151584 | Wiesner et al. | Jun 2017 | A1 |
| 20170199210 | Ang et al. | Jul 2017 | A1 |
| 20170326548 | Tsai et al. | Nov 2017 | A1 |
| 20200009556 | Zimmerley et al. | Jan 2020 | A1 |
| 20200070153 | Tsai et al. | Mar 2020 | A1 |
| 20200347273 | Stockholm et al. | Nov 2020 | A1 |
| Number | Date | Country |
|---|---|---|
| 101498656 | Aug 2009 | CN |
| 101598717 | Dec 2009 | CN |
| 101807705 | Aug 2010 | CN |
| 10014204 | Oct 2001 | DE |
| 10014204 | Oct 2001 | DE |
| 10 2004 052 495 | May 2006 | DE |
| 102004052495 | May 2006 | DE |
| 2007-183258 | Jul 2007 | JP |
| 2291402 | Jan 2007 | RU |
| 201335304 | Sep 2013 | TW |
| WO9844151 | Oct 1998 | WO |
| WO-9844151 | Oct 1998 | WO |
| WO0018957 | Apr 2000 | WO |
| WO-0018957 | Apr 2000 | WO |
| WO0063437 | Oct 2000 | WO |
| WO-0063437 | Oct 2000 | WO |
| WO2005065814 | Jul 2005 | WO |
| WO-2005065814 | Jul 2005 | WO |
| WO2006064199 | Jun 2006 | WO |
| WO-2006064199 | Jun 2006 | WO |
| WO2007010251 | Jan 2007 | WO |
| WO-2007010251 | Jan 2007 | WO |
| WO2007123744 | Nov 2007 | WO |
| WO-2007123744 | Nov 2007 | WO |
| WO-2010009543 | Jan 2010 | WO |
| WO-2010099350 | Sep 2010 | WO |
| WO-2020055732 | Mar 2020 | WO |
| WO-2020236945 | Nov 2020 | WO |
| Entry |
|---|
| Final Office Action dated Sep. 7, 2021 in U.S. Appl. No. 16/457,667 (US 2020-009556). |
| Non-Final Office Action dated Sep. 30, 2021, in U.S. Appl. No. 16/677,501 (US 2020-0070153). |
| Notice of Allowance dated Jan. 11, 2022, in U.S. Appl. No. 16/677,501 (US 2020-0070153). |
| US Office Action dated Dec. 24, 2021 in U.S. Appl. No. 16/457,667 (US 2020-0009556). |
| U.S. Appl. No. 15/926,322, filed Mar. 20, 2018, Feng et al. |
| U.S. Appl. No. 16/000,720, filed Jun. 5, 2018, Feng et al. |
| U.S. Appl. No. 16/457,667, filed Jun. 28, 2019, Zimmerley et al. |
| Applichem GMBH (Darmstadt, Germany), “Contaminations by Nucleic Acids, Problems and Practical Solutions,” Nucleic acid decontamination, Brochure, 2008, 1-64. |
| Chinese Patent Application No. 20098116690.4, Office Action dated Feb. 28, 2013, 9 pages. |
| Chou et al., “Integrated Elastomer Fluidic Lab-on-a-chip-Surface Patterning and DNA Diagnostics,” Proceedings of the Solid State Actuator and Sensor Workshop, Hilton Head, South Carolina, 2000, 4 pages. |
| Dworkin, M. et al., “Life at High Temperatures,” Chapter 1.7, The Prokaryotes: A Handbook on the Biology of Bacteria, Third Edition, vol. 2: Ecophysiology and Biochemistry, 2006, 183-188. |
| Eddings, M. et al., “Determining the optimal PDMS-PDMS bonding technique for microfluidic devices,” J. Micromech. Microeng., 18, 067001, 2008, 4 pages. |
| EP Application No. 09743421.1, Communication Pursuant to Article 94(3) EPC, Oct. 2, 2015, 4 pages. |
| Fiorini, G. et al., “Disposable microfluidic devices: fabrication, function, and application,” BioTechniques, vol. 38 (3), Mar. 2005, 429-446. |
| Flachsbart, B. et al., “Design and fabrication of a multilayered polymer microfluidic chip with nanofluidic interconnects via adhesive contact printing,” Lab on a Chip, 6, 2006, 667-674. |
| Gerday, C. et al., “Extremophiles,” Encyclopedia of life support systems (EOLSS), 2009, 194-203. |
| Grogan, D., “Hyperthermophiles and the problem of DNA instability,” Molecular Microbiology, vol. 28 (6), 1998, 1043-1049. |
| Grover, W. et al., “Monolithic membrane valves and diaphragm pumps for practical large-scale integration into glass microfluidic devices,” Sensors and Actuators B, 89, 2003, 315-323. |
| Karni, M. et al., “Thermal Degradation of DNA,” DNA and Cell Biology, vol. 32 (6), 2013, 1-4. |
| Kim, J. et al., “Rapid prototyping of microfluidic systems using a PDMS/polymer tape composite,” Lab on a Chip, vol. 9, 2009, 1290-1293. |
| Koch Lab: Protocols/Flow cell, https://openwetware.org/mediawiki/index.php?title=Koch_Lab:Protocols/Flow_cell&oldid=397835, accessed on Oct. 25, 2017. |
| Lee, H.-J. et al., “SPR Imaging Measurements of 1-D and 2-D DNA Microarrays Created from Microfluidic Channels on Gold Thin Films,” Anal. Chem. 2001, 73, 2001, 5525-5531. |
| Lindahl, T. et al., “Rate of Depurination of Native Deoxyribonucleic Acid,” Biochemistry, vol. 11 (19), 1972, 3610-3618. |
| Lindahl, T., “Instability and Decay of the Primary Structure of DNA,” Nature, vol. 362, Apr. 22, 1993, 709-715. |
| Long, Z. et al., “Integrated multilayer microfluidic device with a nanoporous membrane interconnect for online coupling of solid-phase extraction to microchip electrophoresis,” Lab Chip, 7, 2007, 1819-1824. |
| Marguet, E. et al., “DNA stability at temperatures typical for hyperthermophiles,” Nucleic acids research, vol. 22 (9), 1994, 1681-1686. |
| Matsunaga et al., “High-Efficiency Single-Cell Entrapment and Fluorescence in Situ Hybridization Analysis Using a Poly(dimethylsiloxane) Microfluidic Device Integrated with a Black Poly(ethylene terephthalate) Micromesh,” Analytical Chemistry, vol. 80, No. 13, (Jun. 7, 2008) pp. 5139-5145 (Year: 2008). |
| Meyers, R., “Denaturation of DNA,” Molecular Biology and Biotechnology: A Comprehensive Desk Reference, 1995, 206-207. |
| Ong, S.E. et al., “Fundamental principles and applications of microfluidic systems,” Frontiers in Bioscience, vol. 13, Jan. 1, 2008, 2757-2773. |
| Shendure, et al., “Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome,” Science, vol. 309, Sep. 9, 2005, 1728-1732. |
| Stroock, A et al., “Components for integrated poly(dimethylsiloxane) microfluidic systems,” Electrophoresis, 23, 2002, 3461-3473. |
| Sun Wei, “Scanning Probe Microscopy Imaging of Biological Origin and FDTD Simulation of Optical Tweezers,” Doctor's Degree Theses from Dalian University of Technology, 2006, 60-67. |
| Yuen, P.K. et al., “Microfluidic devices for fluidic circulation and mixing improve hybridization signal intensity on DNA arrays,” Lab Chip, 3, 2003, 46-50. |
| Zhang, M. et al., “A simple method for fabricating multi-layer PDMS structures for 3D microfluidic chips,” Lab Chip, 10, 2010, 1199-1203. |
| Office Action dated Jun. 25, 2020, in U.S. Appl. No. 16/000,720 (now U.S. Pat. No. Re. 48,561). |
| Notice of Allowance dated Dec. 31, 2020 in U.S. Appl. No. 16/00,0720 (now U.S. Pat. No. Re. 48,561). |
| Office Action dated May 13, 2021, in U.S. Appl. No. 16/457,667 (2020-009556). |
| U.S. Appl. No. 17/214,093, filed Mar. 26, 2021, Feng et al. |
| U.S. Appl. No. 17/683,293, filed Feb. 28, 2022, Shang-Ying Tsai et al. |
| Russian Search Report issued in connection with RU Appl. Ser. No. 2020141569A dated Jul. 26, 2022 (without English translation). |
| Office Action dated Feb. 28, 2013 in Chinese Patent Application No. 200981166904, 9 pages. |
| Communication Pursnant to Article 94(3) EPC for EP Application No. 09743421.1-1562, dated Oct. 2, 2015, 4 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 61138444 | Dec 2008 | US | |
| 61050522 | May 2008 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16000720 | Jun 2018 | US |
| Child | 17214093 | US | |
| Parent | 15926322 | Mar 2018 | US |
| Child | 14721870 | US | |
| Parent | 14229455 | Mar 2014 | US |
| Child | 14721870 | US | |
| Parent | 14056590 | Oct 2013 | US |
| Child | 14229455 | US | |
| Parent | 13974976 | Aug 2013 | US |
| Child | 14056590 | US | |
| Parent | 13629949 | Sep 2012 | US |
| Child | 13974976 | US | |
| Parent | 13544716 | Jul 2012 | US |
| Child | 13629949 | US | |
| Parent | 13399820 | Feb 2012 | US |
| Child | 13544716 | US | |
| Parent | 13281237 | Oct 2011 | US |
| Child | 13399820 | US | |
| Parent | 13209306 | Aug 2011 | US |
| Child | 13281237 | US | |
| Parent | 12434495 | May 2009 | US |
| Child | 13209306 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14721870 | May 2015 | US |
| Child | 16000720 | US | |
| Parent | 14721870 | May 2015 | US |
| Child | 15926322 | US | |
| Parent | 14721870 | May 2015 | US |
| Child | 17214093 | US |
